Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Inflammatory Bowel Disease
•
LFT abnormalities
•
JAK Inhibitors
•
Gastroenterology
•
General Hepatology
•
Primary Care
Would you prescribe a JAK inhibitor in patients with baseline transaminase elevation?
Related Questions
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
What is your approach to choosing a particular advanced therapy based on patient or disease factors when initiating treatment for moderate-severe IBD?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
How do you manage oral ulcers as a side effect from leflunomide?
Are there any recommendations for restarting JAKi after a provoked DVT?
What role do you feel there is for antibiotics in the management of severe perianal Crohn's disease?
How do you help patients understand the difference between prolonged morning stiffness and pain?
What is your approach to management of hyperlipidemia in patients taking JAK inhibitors?
How do people approach non-HIV patients with hepatitis B, a negative Hepatitis B E antigen, normal LFTs and relatively low HBV DNA between 2000-20000?
Have you utilized JAK inhibitors in patients on dialysis?
